Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 27;25(13):7040.
doi: 10.3390/ijms25137040.

Circular RNA hsa_circ_0002268 (PHACTR1) Is Specific to Gestational Diabetes Mellitus in a Polish Pregnant Population

Affiliations

Circular RNA hsa_circ_0002268 (PHACTR1) Is Specific to Gestational Diabetes Mellitus in a Polish Pregnant Population

Dominik Franciszek Dłuski et al. Int J Mol Sci. .

Erratum in

Abstract

Gestational diabetes mellitus (GDM) is an intolerance of carbohydrate of any degree, which appears for the first time or is diagnosed during pregnancy. The objective of this study is to assess the differences in circular RNA (circRNA) in a Polish pregnant population with and without GDM. A total of 62 pregnant women, 34 with GDM and 28 controls, were enrolled in the study. Total RNAs were extracted from plasma and reverse transcription to complementary DNA (cDNA) was performed. A panel covering 271 amplicons, targeting both linear and circular as well as negative control gene transcripts, was used. Next-generation sequencing was used to evaluate the circRNA quantity. Data analysis was performed using the Coverage Analysis plugin in the Torrent Suite Software (Torrent Suite 5.12.3). A two-step normalization was performed by dividing each transcript read count by the total number of reads generated for the sample, followed by dividing the quantity of each transcript by β-actin gene expression. Both circular and linear forms of RNAs were independently evaluated. A total of 57 transcripts were dysregulated between pregnant women with GDM and controls. Most of the targets (n = 25) were downregulated (cut-off ratio below 0.5), and one target showed a trend toward strong upregulation (ratio 1.45). A total of 39 targets were positively correlated with fasting plasma glucose (FPG), but none of the tested targets were correlated with insulin, CRP or HOMA-IR levels. Among the pregnant women with gestational diabetes, the relative quantity of hsa_circ_0002268 (PHACTR1) was approximately 120% higher than among healthy pregnant women: 0.046 [0.022-0.096] vs. 0.021 [0.007-0.047], respectively, (p = 0.0029). Elevated levels of hsa_circ_0002268 (PHACTR1) might be specific to the Polish population of pregnant women with GDM, making it useful as a potential molecular biomarker in the management of GDM in Poland.

Keywords: GDM; PHACTR1; circRNA; hsa_circ_0002268; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Correlation between top 10 dysregulated transcripts and clinical variables (part 1). Abbreviations: CRP, C-reactive protein; FPG, fasting plasma glucose; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance. Significant correlations are marked with a red star. Details are presented in Table 3. (b) Correlation between top 10 dysregulated transcripts and clinical variables (part 2). Abbreviations: please refer to Figure 1a. Significant correlations are marked with a red star. Details are presented in Table 3.

References

    1. Johns E.C., Denison F.C., Norman J.E., Reynolds R.M. Gestational Diabetes Mellitus: Mechanisms, Treatment, and Complications. Trends Endocrinol. Metab. 2018;29:743–754. doi: 10.1016/j.tem.2018.09.004. - DOI - PubMed
    1. Wang H., Li N., Chivese T., Werfalli M., Sun H., Yuen L., Hoegfeldt C.A., Powe C.E., Immanuel J., Karuranga S., et al. IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria. Diabetes Res. Clin. Pract. 2022;183:109050. doi: 10.1016/j.diabres.2021.109050. - DOI - PubMed
    1. Dłuski D.F., Ruszała M., Rudziński G., Pożarowska K., Brzuszkiewicz K., Leszczyńska-Gorzelak B. Evolution of Gestational Diabetes Mellitus across Continents in 21st Century. Int. J. Environ. Res. Public Health. 2022;19:15804. doi: 10.3390/ijerph192315804. - DOI - PMC - PubMed
    1. Casagrande S.S., Linder B., Cowie C.C. Prevalence of gestational diabetes and subsequent Type 2 diabetes among U.S. women. Diabetes Res. Clin. Pract. 2018;141:200–208. doi: 10.1016/j.diabres.2018.05.010. - DOI - PubMed
    1. HAPO Study Cooperative Research Group. Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U., Coustan D.R., Hadden D.R., McCance D.R., Hod M., et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 2008;358:1991–2002. doi: 10.1056/NEJMoa0707943. - DOI - PubMed

LinkOut - more resources